JT

Jeffrey Tong

Partner at Third Rock Ventures

Menlo Park, California

Overview

Work Experience

  • Partner

    2016 - Current

    Focused on building innovative companies to serve patients with significant unmet medical needs. ARTBIO - Board member Asher Biotherapeutics - Board member Candid Therapeutics - Board member Marea Therapeutics - Board member Maze Therapeutics - Board member Rapport Therapeutics (RAPP) - Board member Septerna - Chairman of the board Past companies: Ambys Medicines Nurix (NRIX) Terremoto Biosciences

  • Executive Chairman of the Board

    2016 - 2017

    Served as Executive Chairman and Chairman through $35M Series A financing and subsequent acquisition by Celgene for $775M with $300M upfront.

  • Member of the Board of Directors

    2010 - 2016

  • President & CEO

    2010 - 2015

  • Vice President, Corporate and Product Development

    2001 - 2010

  • Consultant

    2000 - 2001

Relevant Websites